Prognostic Significance of Additional Chromosomal Abnormalities at the Time of Diagnosis in Patients With Chronic Myeloid Leukemia Treated With Frontline Tyrosine Kinase Inhibitors
American Journal of Hematology - United States
doi 10.1002/ajh.24943
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 9, 2017
Authors
Publisher
Wiley